Patents by Inventor Karl L. Mettinger

Karl L. Mettinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
    Patent number: 6977247
    Abstract: A method is provided for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising: administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient; and administering a pyrimidine base analog to the patient.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: December 20, 2005
    Assignee: SuperGen, Inc.
    Inventors: Joseph Rubinfeld, Karl L. Mettinger, John Lyons, Lawrence A. Romel
  • Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
    Publication number: 20030158148
    Abstract: A method is provided for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising: administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient; and administering a pyrimidine base analog to the patient.
    Type: Application
    Filed: February 21, 2002
    Publication date: August 21, 2003
    Inventors: Joseph Rubinfeld, Karl L. Mettinger, John Lyons, Lawrence A. Romel